产品详情
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 27.14 mL | 135.72 mL | 271.44 mL |
0.5 mM | 5.43 mL | 27.14 mL | 54.29 mL |
1 mM | 2.71 mL | 13.57 mL | 27.14 mL |
5 mM | 0.54 mL | 2.71 mL | 5.43 mL |
*The above data is based on the productmolecular weight 368.4 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A11263 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 368.4 |
Formula | C19H24N6O2 |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 859853-30-8 |
Synonyms | BMS690514 |
SMILES | COC1=CC=CC(=C1)NC2=NC=NN3C2=C(C=C3)CN4CC[C@H]([C@@H](C4)O)N |
产品标签
Product Questions
Product Questions
Vandetanib (ZD6474)
Vandetanib (ZD6474)是一种VEGFR和EGFR拮抗剂,是一种酪氨酸激酶抑制剂,对于HUVEC增殖,PC-9细胞和酪氨酸激酶活…
Linifanib (ABT-869)
Linifanib (ABT-869)是一种结构新颖的有效RTK,VEGF和PDGF抑制剂,对人内皮细胞,PDGFR-β,KDR和CSF-1R的IC50分别为0.…
Pazopanib (GW-786034)
Pazopanib (GW-786034)是VEGFR-1,VEGFR-2,VEGFR-3,PDGFR-a/β和c-kit的有效且选择性的多靶点酪氨酸激酶抑制剂,可阻…
Tivozanib (AV-951)
Tivozanib (AV-951)是一种口服VEGF受体酪氨酸激酶抑制剂,旨在抑制所有三种VEGF受体。
Apatinib (YN968D1)
Apatinib (YN968D1)是一种酪氨酸激酶抑制剂,可选择性抑制血管内皮生长因子受体2(VEGFR2,也称为KDR),后者…
Regorafenib (BAY 73-4506)
Regorafenib (BAY 73-4506)是一种多激酶抑制剂,IC50为17、40和69 nM c-KIT,VEGFR2,B-Raf。Regorafenib(BAY 73-4506)是一种…